Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04939012 · ClinicalTrials.gov registry record · NA

Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period

A NA study of Pregnancy Related and Substance Use Disorders, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT04939012 is a NA study of Pregnancy Related and Substance Use Disorders that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 400 participants, below the 1,959-participant average among 99 other Pregnancy Related trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04939012, a NA study of Pregnancy Related and Substance Use Disorders, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This is a study to determine the effect of a novel patient-centered, reproductive planning decision support tool developed by the research team called MyPath on postpartum contraceptive decision-making among women with SUDs.

Interventions

  • BEHAVIORAL Usual care
  • BEHAVIORAL MyPath Intervention

Study Locations (1)

Pennsylvania

  • Magee Womens Hospital of UPMC - Pittsburgh

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2022-10-11
Est. Completion 2027-03-01
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT04939012

The ClinicalTrials.gov registry entry for NCT04939012 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,959-participant average among 99 other Pregnancy Related trials with a reported enrollment target (80% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.

NCT04939012 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04939012 about?

NCT04939012 is a clinical study titled "Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period". This is a study to determine the effect of a novel patient-centered, reproductive planning decision support tool developed by the research team called MyPath on postpartum contraceptive decision-making among women with SUDs.

What is the current status of trial NCT04939012?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2022-10-11. Estimated completion is 2027-03-01.

What conditions does trial NCT04939012 study?

This clinical trial studies the following conditions: Pregnancy Related, Substance Use Disorders, Contraception.

What interventions are being tested in trial NCT04939012?

The interventions under investigation include: Usual care (BEHAVIORAL), MyPath Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04939012?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04939012 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy Related

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.